{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:51:01Z","timestamp":1770839461343,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00520-023-07852-x","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T06:01:46Z","timestamp":1685772106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dexamethasone dose-dependently prevents taxane-associated acute pain syndrome in breast cancer treatment"],"prefix":"10.1007","volume":"31","author":[{"given":"Yoshitaka","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Oshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"key":"7852_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00520-019-04808-y","volume":"28","author":"Y Saito","year":"2020","unstructured":"Saito Y, Kobayashi M, Yamada T, Sakakibara-Konishi J, Shinagawa N, Kinoshita I et al (2020) Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome. Support Care Cancer 28:221\u2013227","journal-title":"Support Care Cancer"},{"key":"7852_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00520-017-3836-z","volume":"26","author":"N Chiu","year":"2018","unstructured":"Chiu N, Zhang L, Dent R, Giotis A, van Draanen J, Gallo-Hershberg D et al (2018) A prospective study of docetaxel-associated pain syndrome. Support Care Cancer 26:203\u2013211","journal-title":"Support Care Cancer"},{"key":"7852_CR3","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.1007\/s00520-021-06342-2","volume":"29","author":"Y Saito","year":"2021","unstructured":"Saito Y, Takekuma Y, Kobayashi M, Sakamoto T, Yamashita H, Sugawara M (2021) Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis. Support Care Cancer 29:8059\u20138067","journal-title":"Support Care Cancer"},{"key":"7852_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"R Peto","year":"2012","unstructured":"Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379:432\u2013444","journal-title":"Lancet"},{"key":"7852_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.2007.11.3787","volume":"26","author":"M De Laurentiis","year":"2008","unstructured":"De Laurentiis M, Cancello G, D\u2019Agostino D, Giuliano M, Giordano A, Montagna E et al (2008) Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol 26:44\u201353","journal-title":"J Clin Oncol"},{"key":"7852_CR6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0959-8049(00)00134-9","volume":"36","author":"JA Kramer","year":"2000","unstructured":"Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG et al (2000) Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. Eur J Cancer 36:1488\u20131497","journal-title":"Eur J Cancer"},{"key":"7852_CR7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/annonc\/mdn781","volume":"20","author":"N Katsumata","year":"2009","unstructured":"Katsumata N, Watanabe T, Minami H, Aogi K, Tabei T, Sano M et al (2009) Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802). Ann Oncol 20:1210\u20131215","journal-title":"Ann Oncol"},{"key":"7852_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.2003.08.013","volume":"21","author":"GW Sledge","year":"2003","unstructured":"Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK et al (2003) Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 21:588\u2013592","journal-title":"J Clin Oncol"},{"key":"7852_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ctrv.2014.02.001","volume":"40","author":"C Megerdichian","year":"2014","unstructured":"Megerdichian C, Olimpiadi Y, Hurvitz SA (2014) nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer. Cancer Treat Rev 40:614\u2013625","journal-title":"Cancer Treat Rev"},{"key":"7852_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00520-015-2941-0","volume":"24","author":"R Fernandes","year":"2016","unstructured":"Fernandes R, Mazzarello S, Majeed H, Smith S, Shorr R, Hutton B et al (2016) Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review. Support Care Cancer 24:1583\u20131594","journal-title":"Support Care Cancer"},{"key":"7852_CR11","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1007\/s00520-016-3256-5","volume":"24","author":"R Fernandes","year":"2016","unstructured":"Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF et al (2016) Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review. Support Care Cancer 24:3633\u20133650","journal-title":"Support Care Cancer"},{"key":"7852_CR12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/bjc.1998.278","volume":"77","author":"H Kunitoh","year":"1998","unstructured":"Kunitoh H, Saijo N, Furuse K, Noda K, Ogawa M (1998) Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion. Br J Cancer 77:1686\u20131688","journal-title":"Br J Cancer"},{"key":"7852_CR13","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20:1\u201315","journal-title":"Semin Oncol"},{"key":"7852_CR14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","volume":"29","author":"CL Loprinzi","year":"2011","unstructured":"Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29:1472\u20131478","journal-title":"J Clin Oncol"},{"key":"7852_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00520-019-04845-7","volume":"28","author":"R Asthana","year":"2020","unstructured":"Asthana R, Zhang L, Wan BA, Gallo-Hershberg D, Giotis A, Pasetka M et al (2020) Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study. Support Care Cancer 28:589\u2013598","journal-title":"Support Care Cancer"},{"key":"7852_CR16","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s00520-018-4571-9","volume":"27","author":"Y Kanbayashi","year":"2019","unstructured":"Kanbayashi Y, Sakaguchi K, Nakatsukasa K, Ouchi Y, Tabuchi Y, Yoshioka T et al (2019) Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysis. Support Care Cancer 27:2673\u20132677","journal-title":"Support Care Cancer"},{"key":"7852_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/gyno.1998.5226","volume":"72","author":"M Markman","year":"1999","unstructured":"Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1999) Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias. Gynecol Oncol 72:100\u2013101","journal-title":"Gynecol Oncol"},{"key":"7852_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00520-008-0508-z","volume":"17","author":"T Yoshida","year":"2009","unstructured":"Yoshida T, Sawa T, Ishiguro T, Horiba A, Minatoguchi S, Fujiwara H (2009) The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer. Support Care Cancer 17:315\u2013320","journal-title":"Support Care Cancer"},{"key":"7852_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/JCO.2004.99.298","volume":"22","author":"VH Nguyen","year":"2004","unstructured":"Nguyen VH, Lawrence HJ (2004) Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. J Clin Oncol 22:1767\u20131769","journal-title":"J Clin Oncol"},{"key":"7852_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2022.05.019","volume":"171","author":"J Zhang","year":"2022","unstructured":"Zhang J, Gao HF, Yang C, Zhu T, Ji F, Yang M et al (2022) Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial. Eur J Cancer 171:150\u2013160","journal-title":"Eur J Cancer"},{"key":"7852_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-015-3573-2","volume":"154","author":"AG Waks","year":"2015","unstructured":"Waks AG, Tolaney SM, Galar A, Arnaout A, Porter JB, Marty FM et al (2015) Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors. Breast Cancer Res Treat 154:359\u2013367","journal-title":"Breast Cancer Res Treat"},{"key":"7852_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1634\/theoncologist.2016-0308","volume":"22","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Ishiguro A, Muranaka T, Fukushima H, Yuki S, Ono K et al (2017) A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01). Oncologist 22:592\u2013600","journal-title":"Oncologist"},{"key":"7852_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/glia.23557","volume":"67","author":"X Yan","year":"2019","unstructured":"Yan X, Li F, Maixner DW, Yadav R, Gao M, Ali MW et al (2019) Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome. Glia 67:482\u2013497","journal-title":"Glia"},{"key":"7852_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12282-011-0297-y","volume":"19","author":"M Hosonaga","year":"2012","unstructured":"Hosonaga M, Ito Y, Tokudome N, Takahashi S, Iwase T, Hatake K (2012) A lower dose of docetaxel at 60 mg\/m(2) could be continued longer for controlling peripheral edema in patients with metastatic breast cancer. Breast Cancer 19:329\u2013334","journal-title":"Breast Cancer"},{"key":"7852_CR25","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","volume":"23","author":"SE Jones","year":"2005","unstructured":"Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E et al (2005) Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 23:5542\u20135551","journal-title":"J Clin Oncol"},{"key":"7852_CR26","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1200\/JCO.2005.05.0294","volume":"24","author":"V Harvey","year":"2006","unstructured":"Harvey V, Mouridsen H, Semiglazov V, Jakobsen E, Voznyi E, Robinson BA et al (2006) Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. J Clin Oncol 24:4963\u20134970","journal-title":"J Clin Oncol"},{"key":"7852_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0749-0690(05)70079-3","volume":"17","author":"SJ Gibson","year":"2001","unstructured":"Gibson SJ, Helme RD (2001) Age-related differences in pain perception and report. Clin Geriatr Med 17:433\u2013456","journal-title":"Clin Geriatr Med"},{"key":"7852_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ejp.1011","volume":"21","author":"H El Tumi","year":"2017","unstructured":"El Tumi H, Johnson MI, Dantas PBF, Maynard MJ, Tashani OA (2017) Age-related changes in pain sensitivity in healthy humans: A systematic review with meta-analysis. Eur J Pain 21:955\u2013964","journal-title":"Eur J Pain"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07852-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:11:08Z","timestamp":1686388268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07852-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7852"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07852-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"372"}}